Hepatorenal Syndrome Type

TGA of Australia Has Approved Ikaria Lucassin
Apr 25, 2012
The Therapeutic Goods Administration (TGA) of Australia has approved Ikaria Lucassin (terlipressin) for the treatment of Hepatorenal Syndrome Type 1 (HRS 1) in patients who are actively being considered for a liver transplant. The ...

Tags: Hepatorenal Syndrome Type 1, HRS, Australia TGA